Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115701) titled 'Clinical research on the improvement of chloasma by the natural peptide molecule AOP-P1' on Dec. 30, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: First Affiliated Hospital of Kunming Medical University
Condition:
Melasma
Intervention:
Experimental Group:Peptide AOP-P1 is soluble in 20% propylene glycol solvent
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2024-10-18
Target Sample Size: Experimental Group:15;Control Group:15;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=301003
Published...